P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma
| প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | English |
| প্রকাশিত: |
Wiley
2022-10-01
|
| মালা: | HemaSphere |
| অনলাইন ব্যবহার করুন: | http://journals.lww.com/10.1097/01.HS9.0000890976.21005.88 |
| _version_ | 1827332213857845248 |
|---|---|
| author | Harsh Shah Victoria Vardell Erin Zacholski Amanda Fegley Kalub Fedak Suchitra Sundaram Sridevi Rajeeve Gaurav Goyal Haris Hatic Pallawi Torka Sheeba Ba Aqeel Azra Borogovac Kira Macdougall Shalin Kothari Anna Kress Dipenkumar Modi Elizabeth Travers Nitin Chilakamarri Elizabeth Brem Deborah M. Stephens Boyu Hu Lindsey Fitzgerlad Charlotte Wagner Daniel Ermann |
| author_facet | Harsh Shah Victoria Vardell Erin Zacholski Amanda Fegley Kalub Fedak Suchitra Sundaram Sridevi Rajeeve Gaurav Goyal Haris Hatic Pallawi Torka Sheeba Ba Aqeel Azra Borogovac Kira Macdougall Shalin Kothari Anna Kress Dipenkumar Modi Elizabeth Travers Nitin Chilakamarri Elizabeth Brem Deborah M. Stephens Boyu Hu Lindsey Fitzgerlad Charlotte Wagner Daniel Ermann |
| author_sort | Harsh Shah |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:55:38Z |
| format | Article |
| id | doaj.art-12d2af81c3be476aa4cbc5e716cec24c |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:55:38Z |
| publishDate | 2022-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-12d2af81c3be476aa4cbc5e716cec24c2024-03-03T04:22:34ZengWileyHemaSphere2572-92412022-10-016474810.1097/01.HS9.0000890976.21005.88202210005-00102P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin LymphomaHarsh Shah0Victoria Vardell1Erin Zacholski2Amanda Fegley3Kalub Fedak4Suchitra Sundaram5Sridevi Rajeeve6Gaurav Goyal7Haris Hatic8Pallawi Torka9Sheeba Ba Aqeel10Azra Borogovac11Kira Macdougall12Shalin Kothari13Anna Kress14Dipenkumar Modi15Elizabeth Travers16Nitin Chilakamarri17Elizabeth Brem18Deborah M. Stephens19Boyu Hu20Lindsey Fitzgerlad21Charlotte Wagner22Daniel Ermann231 University of Utah1 University of Utah2 Virginia Commonwealth University2 Virginia Commonwealth University3 Karmanos Cancer Institute4 Tisch Cancer Institute4 Tisch Cancer Institute5 UAB5 UAB6 Roswell Park Comprehensive Cancer Center6 Roswell Park Comprehensive Cancer Center7 University of Oklahoma7 University of Oklahoma8 Yale Comprehensive Cancer Center8 Yale Comprehensive Cancer Center3 Karmanos Cancer Institute9 University of Kentucky10 University of California, Irvine10 University of California, Irvine1 University of Utah1 University of Utah1 University of Utah1 University of Utah1 University of Utahhttp://journals.lww.com/10.1097/01.HS9.0000890976.21005.88 |
| spellingShingle | Harsh Shah Victoria Vardell Erin Zacholski Amanda Fegley Kalub Fedak Suchitra Sundaram Sridevi Rajeeve Gaurav Goyal Haris Hatic Pallawi Torka Sheeba Ba Aqeel Azra Borogovac Kira Macdougall Shalin Kothari Anna Kress Dipenkumar Modi Elizabeth Travers Nitin Chilakamarri Elizabeth Brem Deborah M. Stephens Boyu Hu Lindsey Fitzgerlad Charlotte Wagner Daniel Ermann P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma HemaSphere |
| title | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_full | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_fullStr | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_full_unstemmed | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_short | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_sort | p102 comparison of novel salvage regimens and traditional salvage chemotherapy in relapsed and refractory classic hodgkin lymphoma |
| url | http://journals.lww.com/10.1097/01.HS9.0000890976.21005.88 |
| work_keys_str_mv | AT harshshah p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT victoriavardell p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT erinzacholski p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT amandafegley p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT kalubfedak p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT suchitrasundaram p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT sridevirajeeve p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT gauravgoyal p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT harishatic p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT pallawitorka p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT sheebabaaqeel p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT azraborogovac p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT kiramacdougall p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT shalinkothari p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT annakress p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT dipenkumarmodi p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT elizabethtravers p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT nitinchilakamarri p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT elizabethbrem p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT deborahmstephens p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT boyuhu p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT lindseyfitzgerlad p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT charlottewagner p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT danielermann p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma |